FEATURED EDITORIAL
A report from WittKieffer's Global Life Sciences provides a macro analysis of the executives that helm today’s CDMOs. Competent executive leadership should be a main driver of business-to-business confidence. So as a component of your CDMO due diligence, are you adequately assessing the senior executives at that organization? If so, do they inspire confidence that theirs is a well-governed and operated entity?
- The Complex Regulatory Landscape Of Flow Cytometry For Cell Therapy
- Aftershocks: Catalent's Leader Assures The Market
- Commissioning & Qualifying: Facility Considerations For Tissue Engineering
- How To Overcome Immune Rejection In iPSC-based Gene Therapy
- Emerging Partnership Trends In Oligo-Based Medicines
- Biopharmaceutical Fermentation Systems' Growing Role In Modern Medicine
- Global CDMOs: What's The Right Price And Location?
GUEST COLUMNISTS
-
Commissioning & Qualifying: Facility Considerations For Tissue Engineering
This article provides an overview of the facility considerations for tissue engineering. It includes a comparison of a bulk biologics facility, which aids the discussion.
-
How To Overcome Immune Rejection In iPSC-based Gene Therapy
Even when induced pluripotent stem cells (iPSCs) are derived from the patient's cells, immune rejection can still occur. This article explores the causes as well as strategies to overcome immune rejection.
-
Emerging Partnership Trends In Oligo-Based Medicines
The oligonucleotides sector is quickly evolving and seeing more industry partnerships than ever before. We caught up with DeciBio's Carl Schoellhammer and Phillip Leclair for their analysis.
-
Biopharmaceutical Fermentation Systems' Growing Role In Modern Medicine
Bioreactors, culture media, growth factors, and sensors are essential to foster microbial or cell growth in optimal conditions.
-
How Ring's Single-capsid Protein Approach Optimizes Viral Delivery
Complexity and manufacturability have an inverse relationship. Ring’s platform seeks to simplify highly complex gene therapy production by making the most of biology.
-
Peptide Synthesis: New Market Research
Peptide synthesis is used to create new vaccines, medications, and enzymes. This article provides an overview of solid phase and liquid phase synthesis as well as new market research.
-
Maintaining Harmony With Your CDMO Using 'The Middle Way'
Sponsor and CDMO relationships are fertile ground for conflict. A measured approach can mitigate disruptions with troublesome contractors and high performers alike.
-
Imbalance In The CDMO Market And The Long-Term Implications
This article explores how the disparity between the number of CDMOs and CGT clinical trials came about and how the market for manufacturing services will change as a result.
PHARMA OUTSOURCING WHITE PAPERS
-
Vial Breakage During Lyophilization: Root Causes And Mitigation
Learn how controlling freezing rates, using specialized vials, and employing optimized stoppering techniques can reduce the risk of vial breakage during lyophilization and ensure high product quality.
-
Enhancing The Solubility Of High Lipophilicity Drugs Via Spray Drying
A new R&D project shows the solubility and dissolution characteristics of Itraconazole can be improved by helping them maintain an amorphous state after spray drying with selected hydrophilic polymers.
-
Spray Drying Biologics: An Alternative To Freeze Drying
Explore how innovative drying technologies can enhance the stability and efficacy of biologics, ensuring successful outcomes in this rapidly growing sector of the pharmaceutical industry.
-
Establishing Analytical Methods For mRNA-Based Therapies
Here, we provide a detailed description of assays for sequence identification and LNP composition in mRNA-LNP products that support the development of safe and effective mRNA therapies.
-
What Pharma And Biopharma Should Know About Container Closure Integrity
Explore high voltage leak detection, headspace analysis, and vacuum and pressure decay as applied in pharmaceutical manufacturing.
-
Streamlining And Standardizing Cell And Gene Therapies From Process To Product
Cell and gene therapies are transforming the lives of patients with various rare genetic diseases and more common conditions such as cancer. However, the rapid pace of scientific progress has overwhelmed supply infrastructure, creating pressures to scale manufacturing, increase capacity and meet a wide range of deliverable requirements.
PHARMA OUTSOURCING APP NOTES & CASE STUDIES
NEWSLETTER ARCHIVE
REPORTING: U.S. BIOSECURE ACT
- BIOSECURE Act Starts Dismantling WuXi
- BIOSECURE Act Passes House. How Will It Impact Your Outsourcing?
- Warning To U.S.-Based CDMOs: Don't Get Complacent
- Clinical Trials In China Reboot BIOSECURE Act
- Breaking: BIOSECURE Act Out. Long Live Wuxi Apptec?
- Assassination By Implication? Interview With WuXi AppTec (Part 2)
- Exclusive Interview: WuXi AppTec Responds To BIOSECURE Act
- Nothing To See Here! Just Big Pharma Investments In China
- You Want To Rein In China? Then Actually Do It
- From Ally To Adversary: BIO's Swift Rebuke Of WuXi
- BIO Expels WuXi, Agrees With U.S. Government
- Is WuXi AppTec An Enemy Of The State?
CONTENT COLLECTIONS
A great resource to help you find and evaluate the best CDMOs in the world. Included in this CDMO Leadership Awards issue are some insightful articles on development and manufacturing outsourcing.
More Content CollectionsPRODUCTS & SERVICES
ON-DEMAND WEBINARS
- Introducing 2 New Highly Effective ADC Payloads For Cancer Therapeutics
- From iPSCs To Functional NK Cell Therapy - A Client Journey
- Regulatory Considerations Including Extractables & Leachables For Single-Use Manufacturing
- How To Plan For Trouble-Free Filter Validation
- Reducing Risks By Outsourcing Your OSD Manufacturing And Packaging